Comprehensive Assessment of Secreted Immuno-Modulatory Cytokines by Serum-Differentiated and Stem-like Glioblastoma Cells Reveals Distinct Differences between Glioblastoma Phenotypes

Glioblastoma is refractory to therapy and presents a significant oncological challenge. Promising immunotherapies have not shown the promise observed in other aggressive cancers. The reasons for this include the highly immuno-suppressive tumour microenvironment controlled by the glioblastoma cells a...

Descripción completa

Detalles Bibliográficos
Autores principales: Robilliard, Laverne D., Yu, Jane, Anchan, Akshata, Finlay, Graeme, Angel, Catherine E., Graham, E Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692434/
https://www.ncbi.nlm.nih.gov/pubmed/36430641
http://dx.doi.org/10.3390/ijms232214164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692434/
https://www.ncbi.nlm.nih.gov/pubmed/36430641
http://dx.doi.org/10.3390/ijms232214164

Ejemplares similares